Movement Alert｜McKesson Rises 3.02% in Regular Trading, Announces Approximately $2.25 Billion Acquisition of Precision Medicine Group

Market Focus08-26 02:55

On August 26, McKesson rose 3.02% in regular trading, trading at $900.22 per share, with turnover of $405 million.

On the news front, McKesson announced it will acquire Precision Medicine Group for approximately $2.25 billion. Upon completion, the acquired business will be reported within McKesson's Oncology and Multispecialty business segment, a strategic move expected to deepen the company's service capabilities in the oncology space.

The acquisition comes on the heels of strong fiscal Q1 2027 results reported earlier this month. Adjusted EPS of $9.93 beat consensus estimates by 4.09%, representing a 20.22% year-over-year increase from $8.26. Revenue of $105.38 billion also exceeded the $103.88 billion estimate. Management simultaneously raised its full-year adjusted EPS guidance to $44.20-$45.00, above the prior range of $43.80-$44.60. Wall Street sentiment remains constructive, with Barclays raising its price target to $1,000, BofA Securities to $1,050, and Citigroup to $1,000, all maintaining bullish ratings.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160286532?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 02:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160286532","market":"us","top_or_hot":-1,"title":"Movement Alert｜McKesson Rises 3.02% in Regular Trading, Announces Approximately $2.25 Billion Acquisition of Precision Medicine Group","media":"Market Focus","content":"<p><p>On August 26, McKesson rose 3.02% in regular trading, trading at $900.22 per share, with turnover of $405 million.</p><p>On the news front, McKesson announced it will acquire Precision Medicine Group for approximately $2.25 billion. Upon completion, the acquired business will be reported within McKesson's Oncology and Multispecialty business segment, a strategic move expected to deepen the company's service capabilities in the oncology space.</p><p>The acquisition comes on the heels of strong fiscal Q1 2027 results reported earlier this month. Adjusted EPS of $9.93 beat consensus estimates by 4.09%, representing a 20.22% year-over-year increase from $8.26. Revenue of $105.38 billion also exceeded the $103.88 billion estimate. Management simultaneously raised its full-year adjusted EPS guidance to $44.20-$45.00, above the prior range of $43.80-$44.60. Wall Street sentiment remains constructive, with Barclays raising its price target to $1,000, BofA Securities to $1,050, and Citigroup to $1,000, all maintaining bullish ratings.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜McKesson Rises 3.02% in Regular Trading, Announces Approximately $2.25 Billion Acquisition of Precision Medicine Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜McKesson Rises 3.02% in Regular Trading, Announces Approximately $2.25 Billion Acquisition of Precision Medicine Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-26 02:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 26, McKesson rose 3.02% in regular trading, trading at $900.22 per share, with turnover of $405 million.</p><p>On the news front, McKesson announced it will acquire Precision Medicine Group for approximately $2.25 billion. Upon completion, the acquired business will be reported within McKesson's Oncology and Multispecialty business segment, a strategic move expected to deepen the company's service capabilities in the oncology space.</p><p>The acquisition comes on the heels of strong fiscal Q1 2027 results reported earlier this month. Adjusted EPS of $9.93 beat consensus estimates by 4.09%, representing a 20.22% year-over-year increase from $8.26. Revenue of $105.38 billion also exceeded the $103.88 billion estimate. Management simultaneously raised its full-year adjusted EPS guidance to $44.20-$45.00, above the prior range of $43.80-$44.60. Wall Street sentiment remains constructive, with Barclays raising its price target to $1,000, BofA Securities to $1,050, and Citigroup to $1,000, all maintaining bullish ratings.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MCK","symbol_name":"麦克森药物批发","start_time":0,"source_url":"","article_id":"1160286532","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160286532","pubTimestamp":1787684130,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 26, McKesson rose 3.02% in regular trading, trading at $900.22 per share, with turnover of $405 million.On the news front, McKesson announced it will acquire Precision Medicine Group for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MCK":"麦克森药物批发"},"translate_title":"走势提醒|麦克森常规交易上涨3.02%，宣布约22.5亿美元收购精准医疗集团","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MCK":1},"content_text":"On August 26, McKesson rose 3.02% in regular trading, trading at $900.22 per share, with turnover of $405 million.On the news front, McKesson announced it will acquire Precision Medicine Group for approximately $2.25 billion. Upon completion, the acquired business will be reported within McKesson's Oncology and Multispecialty business segment, a strategic move expected to deepen the company's service capabilities in the oncology space.The acquisition comes on the heels of strong fiscal Q1 2027 results reported earlier this month. Adjusted EPS of $9.93 beat consensus estimates by 4.09%, representing a 20.22% year-over-year increase from $8.26. Revenue of $105.38 billion also exceeded the $103.88 billion estimate. Management simultaneously raised its full-year adjusted EPS guidance to $44.20-$45.00, above the prior range of $43.80-$44.60. Wall Street sentiment remains constructive, with Barclays raising its price target to $1,000, BofA Securities to $1,050, and Citigroup to $1,000, all maintaining bullish ratings.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160286532","isCrawlerRequest":true}